$FORR

Forrester Research, Inc. Q2 2026 Earnings Call Summary

Forrester Research reported Q2 2026 results and reiterated full-year 2026 guidance. Management cited stabilization in core Contract Value, while non-CV revenue fell 15% due to strategy consulting exit and market uncertainty. Events revenue declined 17%. Forrester AI usage rose 69% YoY. The company plans to fully exit consulting by end-2026 and expects stock repurchases using over $76 million authorization.

Original reporting
Published Aug 1, 2026, 7:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 1, 2026, 7:50 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Forrester Research, Inc. Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$FORRNeutralMed
01

Why it matters

Traders can update expectations for 2026 contract value trajectory based on management’s maintained guidance, the planned end-2026 exit of strategy consulting, and the planned acceleration of stock repurchases in H2.

02

Market read

Guidance is maintained and buybacks are set to accelerate, but the full-year model still assumes mid-single-digit research decline, low-20s consulting decline, and mid-to-high-teens events decline.

03

What to watch

The article notes competitive dynamics shifting marketing agency AI usage away from OpenAI toward Google and Adobe, which could foreshadow broader platform-driven demand shifts for research providers.

Relevance 6/10Novelty 5/10Timing: ahead of/into Q2 earnings positioning for 2026 guidance and buyback expectations

Background

This is a Q2 2026 earnings call summary describing Forrester’s segment performance, strategic pivot away from strategy consulting, AI product usage, and full-year 2026 guidance assumptions.

Company-level read

Ticker impact

$FORRNeutralMedium confidence
Context

Forrester (FORR) maintained full-year 2026 guidance while detailing a full exit from strategy consulting by end-2026 and a stock repurchase acceleration using $76M+ authorization.

Expected impact

Moderate upside bias on any market focus on buyback and CV stabilization, offset by continued full-year contraction assumptions.

Evidence & confidence

The article provides specific management guidance assumptions, a timeline for exiting consulting, and a quantified remaining repurchase authorization, which can move expectations even without new beats/misses.

Market effects

Highlights competitive pressure in AI research/workflow integrations and a shift toward “answer engine optimization,” which may influence how research vendors market and price AI-enabled offerings.

North American federal government segment flagged as a headwind with an anticipated Q3 turning point, relevant for demand timing in government-adjacent research spend.

Expansion of Total Experience (TX) scoring to employee experience and global brand-growth measurement may affect cross-region client evaluation of research subscriptions.

Counterpoint

The narrative of CV stabilization may be offset by ongoing contraction in non-CV lines and reliance on assumed declines, so the buyback could be more supportive than fundamentally corrective.

Key entities

  • Forrester Research, Inc.

    Discussed Q2 performance drivers, full-year 2026 guidance assumptions, strategy consulting exit timeline, AI product usage growth, and H2 stock repurchase acceleration.

  • Microsoft Teams and Copilot

    Management claims early competitive positioning via presence in Microsoft Teams and an AI agent for Copilot.

  • North American government segment

    Flagged as a recent headwind with an expected turning point in Q3.

Related articles

$FORRMedAI 8/10

Forrester (FORR) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer and Chairman - George F. Colony Chief Financial Officer - Leo Christian Finn Vice President of Corporate Development, and Investor Relations - Ed Bryce Morris Chief Product Officer - Carrie Johnson Fanlo Chief Sales Officer - Christophe Favre TAKEAWAYS Total Revenue -- Forrester Research, Inc.

$FORRHigh

FORRESTER RESEARCH, INC. (FORR): Results of Operations and Financial Condition

FORRESTER RESEARCH, INC. (FORR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 forr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Forrester Research Reports 2026 Second-Quarter Financial Results CAMBRIDGE, Mass., July 30, 2026 — Forrester Research, Inc. (Nasdaq: FORR) today announced financial results for the second quarter ended J

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.